Eyecare practitioners urged to provide emergency care only amid COVD-19

Article

woman in mask


Recommendations and guidance for consumers and healthcare professionals regarding novel coronavirus 2019 and associated COVID-19 are coming quickly, and these updates are changing day by day.

Related: Coronavirus: A quick summary for optometrists

However, this week has seen tremendous change in how the United States overall is addressing the pandemic with city lockdowns and more business closures and travel restrictions in an effort to reduce the spread of the virus.

Meanwhile, U.S. clinicians have started a petition for the federal government to impose a national quarantine, among other things.

Most eyecare practitioners have been increasing hand washing and in-office disinfection procedures while following social distance recommendations and suggesting patients and staff who are sick to remain at home.

Related: How ODs are addressing COVID-19 in their practices

That changed this week when the Centers for Disease Control and Prevention (CDC) recommended that doctors and patients postpone routine eye exams.

The California Optometric Association was the first group to issue guidance-early in the week it communicated to its members that it strongly recommended that ODs practicing in California voluntarily suspend nonessential or nonurgent optometry care for the next 14 days.

The American Academy of Ophthalmology followed suit yesterday with its own guidance. It recommends that “all ophthalmologists cease providing any treatment other than urgent or emergent care immediately.”

Related: COVID-19 and contact lens wear: What ODs and patients need to know

AOA guidance
Today, the American Optometric Association (AOA) released a statement agreeing with the CDC’s stance that ODs should focus on urgent and emergent care to patients.

Per the statement: Based on the immediate health needs of a patient, doctors of optometry can and should use their professional judgment to determine the timing and course of care, including assessing patient expressed urgency, necessary preventative care, and the monitoring and refilling of prescriptions.  

However, this does not mean that ODs should close their practices.

Offices do not have to close down, says Barbara Horn, OD, president of the AOA. ODs should bring in someone if it is an emergency unless the patient is sick.

“You don’t need to shut your doors and walk away,” she says. “In fact, you should be answering the phone. We shouldn’t abandon our patients. Closing the doors isn’t the recommendation; it is to limit and postpone what can be postponed. Eye care is essential. We need to be there for emergency patients. Patients call when they are blurry, but we need to triage and talk with patients calling in. Find out if they have a fever or respiratory problems or feel ill. If so, they need to communicate with their primary-care doctors.”

Dr. Horn says that speaking with patients about their symptoms will determine if they need to be seen urgently-such as waking up with suddenly blurry vision-or can be scheduled for a visit in several weeks.

“ODs need to be communicating with patients,” she says.”Normally they come in, and we get their case histories. We need to get that information when they call. Talk with patients to determine who can wait a few weeks and who can’t.”

She reminds ODs that focusing on emergency care only is not a mandate from the CDC but a recommendation.

‘Uncharted territory’
Chief Optometric Editor Ben Casella, OD, FAAO, says that everyone, including ODs, is in uncharted territory right now, and all are doing their best to do the right thing in the hopes of slowing the spread of the novel virus.

Related: One OD weighs in during office closure

Related: Dr. Ben Casella weighs in COVID-19

“The CDC recommendations for postponing all routine eye care is the latest development for optometry with respect to COVID-19, and many of us have questions,” he says. “The exact length of time of postponement seems as elusive as the virus, itself. We have to be patient while the details continue to unfold, and we have to wait for some sign that what we are doing is working. Speaking on the phone with a colleague last night, the difficulty of defining the very word ‘routine’ came up. None of us want to postpone the patient who thinks his vision is fuzzy because his glasses are old but really has a retinal detachment or a brain tumor.”

Dr. Casella continues: “These are just the cards we are dealt today. What will the cards look like tomorrow? A week from now? Two months from now? The only way to get past this is to follow guidance as to how best to defeat this virus.”

Optometry’s Meeting still a go
In related news, the AOA’s annual meeting planned for late June 2020, has not been cancelled or postponed.

Dr. Horn says that she and AOA leadership are hoping that extreme measures taken now will slow the spread of the virus.

“In two to three weeks we will have a better handle on if we need to start figuring it out,” she says. “At this point, we are not cancelling Optometry’s Meeting.”

 

Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
© 2024 MJH Life Sciences

All rights reserved.